IFNG and major depressive disorder: Increased IFN-γ levels were observed after treatment with duloxetine and paroxetine in patients with MDD [19,23], while decreases in IFN-γ concentrations to levels observed in healthy individuals were reported with treatment of sertraline, ketamine, and venlafaxine [19,22].